Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
Kumiko UmemotoYu SunakawaMakoto UenoMasayuki FurukawaNobumasa MizunoKentaro SudoYasuyuki KawamotoTakeshi KajiwaraKoushiro OhtsuboNaohiro OkanoNobuhisa MatsuhashiShinji ItohToshihiko MatsumotoSatoshi ShimizuToru OtsuruHiroko HasegawaHiroyuki OkuyamaHideko OhamaToshikazu MoriwakiTakashi OhtaJustin I OdegaardYoshiaki NakamuraHideaki BandoTakayuki YoshinoMasafumi IkedaChigusa MorizanePublished in: British journal of cancer (2023)
The prevalence of KRAS mutations and maximum VAF were higher in patients with metastasis to the liver than in those with metastasis to other sites. This study indicated the clinical utility of ctDNA analysis, especially in PDAC with liver metastases.